Provision of cancer care during the COVID-19 pandemic

被引：74
作者：
Spicer, James [1 ,2 ]
Chamberlain, Charlotte [3 ]
Papa, Sophie [1 ,2 ]
机构：
[1] Kings Coll London, Sch Canc & Pharmaceut Sci, London, England
[2] Guys & St Thomas NHS Fdn Trust, London, England
[3] Univ Bristol Sch Med, Populat Hlth Sci, Bristol, Avon, England
来源：
NATURE REVIEWS CLINICAL ONCOLOGY | 2020年 / 17卷 / 06期
关键词：
D O I：
10.1038/s41571-020-0370-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Health-care services are rapidly transforming their organization and workforce in response to the coronavirus disease 2019 (COVID-19) pandemic. These changes, and a desire to mitigate infection risk, are having profound effects on other vital aspects of care, including the care of patients with cancer. Difficult decisions are being made regarding the prioritization of both active treatments and palliative care, despite limited evidence that cancer is an independent risk factor for infection and mortality.
引用
收藏
页码：329 / 331
页数：3
相关论文
共 10 条
  • [1] Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy
    Grasselli, Giacomo
    Zangrillo, Alberto
    Zanella, Alberto
    Antonelli, Massimo
    Cabrini, Luca
    Castelli, Antonio
    Cereda, Danilo
    Coluccello, Antonio
    Foti, Giuseppe
    Fumagalli, Roberto
    Iotti, Giorgio
    Latronico, Nicola
    Lorini, Luca
    Merler, Stefano
    Natalini, Giuseppe
    Piatti, Alessandra
    Ranieri, Marco Vito
    Scandroglio, Anna Mara
    Storti, Enrico
    Cecconi, Maurizio
    Pesenti, Antonio
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (16): : 1574 - 1581
  • [2] Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic
    Hanna, Timothy P.
    Evans, Gerald A.
    Booth, Christopher M.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2020, 17 (05) : 268 - 270
  • [3] Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
    Liang, Wenhua
    Guan, Weijie
    Chen, Ruchong
    Wang, Wei
    Li, Jianfu
    Xu, Ke
    Li, Caichen
    Ai, Qing
    Lu, Weixiang
    Liang, Hengrui
    Li, Shiyue
    He, Jianxing
    [J]. LANCET ONCOLOGY, 2020, 21 (03) : 335 - 337
  • [4] NHS England, 2020, CLIN GUID MAN NONC P
  • [5] Palmieri, 2020, CHARACTERISTICS COVI
  • [6] Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence
    Russell, Beth
    Moss, Charlotte
    George, Gincy
    Santaolalla, Aida
    Cope, Andrew
    Papa, Sophie
    Van Hemelrijck, Mieke
    [J]. ECANCERMEDICALSCIENCE, 2020, 14 : 1 - 43
  • [7] The UK National Institute of Health and Care Excellence, 2020, COVID 19 RAP GUID DE
  • [8] Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
    Wu, Zunyou
    McGoogan, Jennifer M.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (13): : 1239 - 1242
  • [9] Risk of COVID-19 for patients with cancer
    Xia, Yang
    Jin, Rui
    Zhao, Jing
    Li, Wen
    Shen, Huahao
    [J]. LANCET ONCOLOGY, 2020, 21 (04) : E180 - E180
  • [10] Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
    Zhou, Fei
    Yu, Ting
    Du, Ronghui
    Fan, Guohui
    Liu, Ying
    Liu, Zhibo
    Xiang, Jie
    Wang, Yeming
    Song, Bin
    Gu, Xiaoying
    Guan, Lulu
    Wei, Yuan
    Li, Hui
    Wu, Xudong
    Xu, Jiuyang
    Tu, Shengjin
    Zhang, Yi
    Chen, Hua
    Cao, Bin
    [J]. LANCET, 2020, 395 (10229) : 1054 - 1062
1